Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile

Background: The target product profile (TPP) outlines the desired profile of a target product aimed at a particular disease and is used by companies to plan clinical development. Considering the increasing importance of health technology assessment (HTA) in informing reimbursement decisions, a robus...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, McAuslane, Neil, Goettsch, Wim G., Leufkens, Hubert G. M., De Bruin, Marie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340272/
https://www.ncbi.nlm.nih.gov/pubmed/35924050
http://dx.doi.org/10.3389/fphar.2022.948161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340272/
https://www.ncbi.nlm.nih.gov/pubmed/35924050
http://dx.doi.org/10.3389/fphar.2022.948161

Ejemplares similares